Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.
about
Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesisTargeting NADPH oxidases for the treatment of cancer and inflammationHonokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivoReactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) miceRho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth.Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates.Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysTumor necrosis factor-related apoptosis-inducing ligand can induce apoptosis in subsets of premalignant cells.Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis.Dual Roles of METCAM in the Progression of Different Cancers.Honokiol: a potent chemotherapy candidate for human colorectal carcinomaAlterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.The reactive oxygen-driven tumor: relevance to melanoma.Fighting cancer with red wine? Molecular mechanisms of resveratrol.The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.Naturally occurring proteasome inhibitors from mate tea (Ilex paraguayensis) serve as models for topical proteasome inhibitors.Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling.Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor.Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.Confirmation of a linkage between H-Ras and MMP-13 expression as well as MMP-9 by chemical genomic approach.Targeting the duality of cancer.
P2860
Q24681382-977C926C-DB4B-4E69-A0A5-1798402A719BQ26851163-34CEF5B4-E89C-4255-968A-74D5D95AFDC2Q28180577-244980FD-6F6F-453A-904F-F1C288E1A7B2Q33714992-40E87C58-4D3D-4408-A70F-F2F963EAF37AQ33808187-F6597899-29C5-4E31-BFE6-1F3E0E61E61EQ33909559-E5D69904-73DF-4C60-8686-5989C3D319C2Q33944527-8C896351-19CB-4FE9-B83B-7A2700AD2A80Q35054868-B7F21C0F-6EC5-4548-BF93-7217B59B6C35Q35103344-4E362F33-2E5C-4086-B38E-E077CE05BB35Q35776264-90E7F08F-102A-43D5-BFDA-18980C7A5B17Q35789048-D1E20771-4DF6-427C-BED4-70A066FE28ECQ35875771-B1309D4A-C747-44E5-9D90-F234D01FABAAQ36076361-97C0FA65-5626-4206-B5E0-31C8FF30BC32Q36210054-82D1F012-A34E-4609-B955-D955FF77C539Q37126796-6C295318-23B0-4380-8FD5-66B7BE208309Q37742528-36BB375E-3129-4FED-9B46-57B8B71FD37AQ38261369-8EACFE21-22C9-4F0A-A6FE-9AA7388FA27CQ40385949-2BD5A468-8F99-44F8-8513-0193D65842A9Q40679352-F2871ECD-B85D-4C2A-B1C8-3FD76EE60166Q41138480-FFD65F25-825A-49E9-A422-575FCC89CBB2Q42792204-AC2A30B3-9C90-4C99-B98C-93CE1E013571Q46138405-8304B358-C687-4B01-B36F-60E16DEEEB06Q46838385-1C5A969B-2E9B-45D5-A2A8-E0CEA1C89173Q52539731-36D46868-47E9-490C-9BE5-62A57DA2B65B
P2860
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@ast
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@en
type
label
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@ast
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@en
prefLabel
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@ast
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@en
P2093
P2860
P1476
Inhibition of MAP kinase kinas ...... genesis in angiosarcoma cells.
@en
P2093
D Wiederschain
H Ghazizadeh
J L Arbiser
K R LaMontagne
P2860
P304
P356
10.1016/S0002-9440(10)64832-8
P407
P577
2000-12-01T00:00:00Z